NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
18.08
-0.78 (-4.14%)
Mar 31, 2025, 10:11 AM EDT - Market open

NovoCure Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
605.22509.34537.84535.03494.37
Upgrade
Revenue Growth (YoY)
18.82%-5.30%0.53%8.23%40.72%
Upgrade
Cost of Revenue
136.18127.54114.26114.24106.09
Upgrade
Gross Profit
469.05381.8423.58420.79388.27
Upgrade
Selling, General & Admin
427.21386.97306.41263.18225.45
Upgrade
Research & Development
209.37220.99206.09201.3132.01
Upgrade
Operating Expenses
636.58607.96512.5464.49357.46
Upgrade
Operating Income
-167.54-226.16-88.91-43.6930.81
Upgrade
Interest Expense
-10.34-3.32-3.33-3.44-17.58
Upgrade
Interest & Investment Income
22.7219.6410.960.791.79
Upgrade
Currency Exchange Gain (Loss)
-0.72-0.8-3.52-4.032.65
Upgrade
Other Non Operating Income (Expenses)
-0.6-0.79-1.26-1.37-0.47
Upgrade
EBT Excluding Unusual Items
-156.48-211.42-86.06-51.7417.2
Upgrade
Merger & Restructuring Charges
-2-6.23---
Upgrade
Gain (Loss) on Sale of Investments
28.2726.44.830.311.32
Upgrade
Asset Writedown
-0.95-0.48-0.61-0.64-0.41
Upgrade
Pretax Income
-131.16-191.74-81.85-52.0818.1
Upgrade
Income Tax Expense
37.4715.310.696.28-1.71
Upgrade
Net Income
-168.63-207.04-92.53-58.3519.81
Upgrade
Net Income to Common
-168.63-207.04-92.53-58.3519.81
Upgrade
Shares Outstanding (Basic)
108106105103101
Upgrade
Shares Outstanding (Diluted)
108106105103109
Upgrade
Shares Change (YoY)
1.36%1.65%1.19%-5.00%11.97%
Upgrade
EPS (Basic)
-1.56-1.95-0.88-0.560.20
Upgrade
EPS (Diluted)
-1.56-1.95-0.88-0.560.18
Upgrade
Free Cash Flow
-69.22-100.439.4358.5984.18
Upgrade
Free Cash Flow Per Share
-0.64-0.940.090.570.77
Upgrade
Gross Margin
77.50%74.96%78.76%78.65%78.54%
Upgrade
Operating Margin
-27.68%-44.40%-16.53%-8.17%6.23%
Upgrade
Profit Margin
-27.86%-40.65%-17.21%-10.91%4.01%
Upgrade
Free Cash Flow Margin
-11.44%-19.72%1.75%10.95%17.03%
Upgrade
EBITDA
-157.67-216.46-79.34-34.5338.56
Upgrade
EBITDA Margin
-26.05%-42.50%-14.75%-6.45%7.80%
Upgrade
D&A For EBITDA
9.879.79.579.177.75
Upgrade
EBIT
-167.54-226.16-88.91-43.6930.81
Upgrade
EBIT Margin
-27.68%-44.40%-16.53%-8.17%6.23%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q